Key facts
- Infera Health’s last known valuation is $10.0M (Feb 2025).
- It has raised $2.6M; the latest was Seed Round ($2.6M) in Feb 2025.
- Notable investors include Correlation Ventures, Founder Collective.
- Infera Health has filed 1 Form D with the SEC, most recently Mar 2025 ( sold to 5 investors).
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Infera Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Infera Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Infera Health
Provider of compliance-automation software intended for medtech governance purposes. The company's platform integrates agent-based workflow orchestration, traceability linking across artifacts and standards, change control automation, tool-chain connectors, and live audit reporting, enabling device manufacturers and regulatory teams to streamline quality documentation, reduce manual review burden, maintain consistent regulatory alignment, and accelerate product release cycles.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2024
- Website
- infera.com/
- Ownership
- Privately Held (backing)
Infera Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Infera Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Infera Health in its N-PORT filings yet. We sweep new filings monthly.